Streetbeat News

Analyst Ratings

W

Stephens & Co. analyst Nicholas Zangler maintains an Overweight rating on Wayfair (NYSE:W) but has lowered the price target from $105 to $75.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 2:27 pm

RM

Stephens & Co. analyst Vincent Caintic maintains an Equal-Weight rating on Regional Mgmt (NYSE:RM) and lowers the price target from $38 to $30.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 2:24 pm

CGNX

Stephens & Co. analyst Tommy Moll maintains an Equal-Weight rating on Cognex (NASDAQ:CGNX) and lowers the price target from $55 to $40.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 2:23 pm

WING

Stephens & Co. analyst Joshua Long has reiterated an Overweight rating on Wingstop (NASDAQ:WING) and maintained a price target of $240.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 2:21 pm

MUSA

Stephens & Co. analyst Ben Bienvenu has reiterated an Overweight rating on Murphy USA (NYSE:MUSA) and maintained a price target of $410.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 2:19 pm

BTCUSD

MSTR

Equity research firm Canaccord Genuity has set a share price target of $554 for MicroStrategy Incorporated (NASDAQ:MSTR), citing the company's successful adoption of Bitcoin as its primary treasury reserve asset. The firm's valuation methodology includes a 30% premium to MicroStrategy's software business and a 20% premium to its current Bitcoin reserves. MicroStrategy's shares have surged by 242% since August 2020, and the company added 6,067 Bitcoin to its holdings in Q3, bringing its total to 158,245 Bitcoin.

Portfolio Pulse from Murtuza Merchant

November 02, 2023 | 2:17 pm

AAPL

Apple Inc. is expected to release its Q4 financial results on Nov. 2, 2023. Analysts predict earnings of $1.39 per share, up from $1.29 per share a year ago, and revenue of $89.28 billion, down from $90.15 billion. Apple has reportedly stopped efforts to make its Apple Watch and Health app compatible with Android devices. The company's shares gained 1.9% to close at $173.97 on Wednesday. Several analysts have provided their ratings and price targets for Apple.

Portfolio Pulse from Lisa Levin

November 02, 2023 | 2:16 pm

CAKE

Stephens & Co. analyst Joshua Long maintains an Overweight rating on Cheesecake Factory (NASDAQ:CAKE) but lowers the price target from $40 to $35.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 2:07 pm

MLM

Stephens & Co. analyst Trey Grooms maintains an Overweight rating on Martin Marietta Materials (NYSE:MLM) and raises the price target from $525 to $540.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 2:06 pm

MLYS

Mineralys Therapeutics (NASDAQ:MLYS) presented a new post-hoc analysis from the Target-HTN Phase 2 trial of lorundrostat, a treatment for uncontrolled or treatment-resistant hypertension. The analysis supports obesity-associated dysregulated aldosterone as an endotype predictive of enhanced response to lorundrostat treatment. The ongoing Advance-HTN trial will further characterize hypertensive endotype for enhanced response to lorundrostat treatment.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 2:05 pm